Cargando…
Antiangiogenic drugs in combination with seaweed fucoidan: A mechanistic in vitro and in vivo study exploring the VEGF receptor and its downstream signaling molecules in hepatic cancer
Hepatocellular carcinoma (HCC) is one of the most common cancers reported worldwide with poor morbidity and high mortality rates. HCC is a very vascular solid tumour as angiogenesis is not only a key driver for tumour progression but also an exciting therapeutic target. Our research investigated the...
Autores principales: | Abdollah, Maha R. A., Ali, Aya A., Elgohary, Hassnaa H., Elmazar, Mohamed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982147/ https://www.ncbi.nlm.nih.gov/pubmed/36874031 http://dx.doi.org/10.3389/fphar.2023.1108992 |
Ejemplares similares
-
Fucoidans: Downstream Processes and Recent Applications
por: Zayed, Ahmed, et al.
Publicado: (2020) -
Anti-inflammatory properties of antiangiogenic fucoidan in retinal pigment epithelium cells
por: Dörschmann, Philipp, et al.
Publicado: (2023) -
Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance
por: Reyes, María Elena, et al.
Publicado: (2020) -
In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds
por: Sanniyasi, Elumalai, et al.
Publicado: (2023) -
Antiangiogenic VEGF Isoform in Inflammatory Myopathies
por: Volpi, Nila, et al.
Publicado: (2013)